Patheon, a global provider of drug development and delivery solutions to the pharmaceutical and biopharma industries, has joined the American Business Act on Climate Pledge. The company joins more than 140 companies from across the American economy that are standing with the Obama Administration to demonstrate an ongoing commitment to climate action, and to voice support for a strong outcome to the COP21 Paris climate negotiations.
The American Business Act on Climate Pledge: As a global company, we applaud the growing number of countries that have already set ambitious targets for climate action. In this context, we support the conclusion of a climate change agreement in Paris that takes a strong step forward toward a low-carbon, sustainable future. We recognize that delaying action on climate change will be costly in economic and human terms, while accelerating the transition to a low-carbon economy will produce multiple benefits with regard to sustainable economic growth, public health, resilience to natural disasters, and the health of the global environment.
“By joining the American Business Act on Climate Pledge, Patheon is cementing its commitment and reinforcing the need for an effective and sustainable lasting climate change agreement among leading companies,” said Harry Gill, senior vice president, quality and continuous improvement, Patheon. “We recognize that environmental health and human health are inextricably linked and we are committed to a Healthier World.”
Along with the other concerned companies, Patheon announces its specific pledges to:
- Solid Waste: A commitment of zero waste to landfill by year 2020.
- Energy: A 30 percent reduction in energy use by year 2020.
- Water: A 10 percent reduction in water withdrawal by year 2020.
